semaglutide mice dose Pharmacokinetic behavior of ALT-801 and in C57Bl/6J Obese mice weight loss role

Ozempic is approved for type 2 diabetes glycemic control (2017), cardiovascular risk reduction in T2D (2020), and CKD progression in T2D (February 2026)

Real Results, Real Support - Our San Antonio patients experience lasting change through customized care that focuses on long-term success, not just quick fixes

This weight regain occurs because the medications appetite suppression effects wear off, hunger and cravings return, and without ongoing treatment, the physiological factors that contributed to weight gain resume

As of March 2026, a higher dose of 7.2 mg per week has been approved for eligible patients in the U.S

GLP-1 receptor agonists represent an entire shift in what medicine can do to help people lose weight and get healthier